• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Supervised Bayesian latent class models for high-dimensional data.监督贝叶斯潜在类别模型在高维数据中的应用。
Stat Med. 2012 Jun 15;31(13):1342-60. doi: 10.1002/sim.4448. Epub 2012 Apr 11.
2
High CHI3L1 expression is associated with glioma patient survival.几丁质酶3样蛋白1(CHI3L1)高表达与胶质瘤患者的生存率相关。
Diagn Pathol. 2016 Apr 27;11:42. doi: 10.1186/s13000-016-0492-4.
3
Protein and mRNA levels of YKL-40 in high-grade glioma.高级别胶质瘤中YKL-40的蛋白质和mRNA水平
Folia Biol (Praha). 2014;60(6):261-7. doi: 10.14712/fb2014060060261.
4
Serum YKL-40 is a marker of prognosis and disease status in high-grade gliomas.血清 YKL-40 是高级别胶质瘤预后和疾病状态的标志物。
Neuro Oncol. 2011 Nov;13(11):1244-51. doi: 10.1093/neuonc/nor117. Epub 2011 Aug 10.
5
Extraneural metastases in glioblastoma patients: two cases with YKL-40-positive glioblastomas and a meta-analysis of the literature.胶质母细胞瘤患者的神经外转移:两例YKL-40阳性胶质母细胞瘤病例及文献荟萃分析
Neurosurg Rev. 2016 Jan;39(1):37-45; discussion 45-6. doi: 10.1007/s10143-015-0656-9. Epub 2015 Jul 28.
6
Gene expression microarray analysis reveals YKL-40 to be a potential serum marker for malignant character in human glioma.基因表达微阵列分析显示,YKL-40是人类胶质瘤恶性特征的潜在血清标志物。
Cancer Res. 2002 Aug 1;62(15):4364-8.
7
Prognostic significance of histological grading, p53 status, YKL-40 expression, and IDH1 mutations in pediatric high-grade gliomas.组织学分级、p53 状态、YKL-40 表达和 IDH1 突变对儿童高级别胶质瘤的预后意义。
J Neurooncol. 2010 Sep;99(2):209-15. doi: 10.1007/s11060-010-0129-5. Epub 2010 Feb 21.
8
Extent of tumor removal and molecular markers in cerebral glioblastoma: a combined prognostic factors study in a surgical series of 105 patients.脑胶质母细胞瘤的肿瘤切除程度和分子标志物:一项 105 例手术系列的综合预后因素研究。
J Neurosurg. 2012 Aug;117(2):204-11. doi: 10.3171/2012.4.JNS101702. Epub 2012 Jun 1.
9
YKL-40 is directly produced by tumor cells and is inversely linked to EGFR in glioblastomas.YKL-40由肿瘤细胞直接产生,在胶质母细胞瘤中与表皮生长因子受体呈负相关。
Int J Clin Exp Pathol. 2010 Jan 1;3(3):226-37.
10
CHI3L1 (YKL-40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells.CHI3L1(YKL-40)在人类神经胶质瘤中表达,并调节神经胶质瘤细胞的侵袭、生长和存活。
Int J Cancer. 2011 Mar 15;128(6):1316-26. doi: 10.1002/ijc.25466.

引用本文的文献

1
OUTCOME-GUIDED DISEASE SUBTYPING BY GENERATIVE MODEL AND WEIGHTED JOINT LIKELIHOOD IN TRANSCRIPTOMIC APPLICATIONS.转录组学应用中基于生成模型和加权联合似然性的结果导向疾病亚型分类
Ann Appl Stat. 2024 Sep;18(3):1947-1964. doi: 10.1214/23-aoas1865. Epub 2024 Aug 5.
2
Regularized Latent Class Analysis for Polytomous Item Responses: An Application to SPM-LS Data.多分类项目反应的正则化潜在类别分析:在SPM-LS数据中的应用
J Intell. 2020 Aug 14;8(3):30. doi: 10.3390/jintelligence8030030.
3
Biclustering Models for Two-Mode Ordinal Data.二模有序数据的双聚类模型
Psychometrika. 2016 Sep;81(3):611-24. doi: 10.1007/s11336-016-9503-3. Epub 2016 Jun 21.
4
A latent class model with hidden Markov dependence for array CGH data.一种用于阵列比较基因组杂交(array CGH)数据的具有隐藏马尔可夫依赖性的潜在类别模型。
Biometrics. 2009 Dec;65(4):1296-305. doi: 10.1111/j.1541-0420.2009.01226.x.

本文引用的文献

1
Regularized finite mixture models for probability trajectories.用于概率轨迹的正则化有限混合模型。
Psychometrika. 2008 Dec;73(4):625-646. doi: 10.1007/s11336-008-9077-9.
2
Pairwise variable selection for high-dimensional model-based clustering.基于高维模型的聚类的成对变量选择。
Biometrics. 2010 Sep;66(3):793-804. doi: 10.1111/j.1541-0420.2009.01341.x.
3
Feature selection for predicting tumor metastases in microarray experiments using paired design.使用配对设计在微阵列实验中预测肿瘤转移的特征选择
Cancer Inform. 2007 Mar 20;3:213-8.
4
Variable selection for model-based high-dimensional clustering and its application to microarray data.基于模型的高维聚类的变量选择及其在微阵列数据中的应用。
Biometrics. 2008 Jun;64(2):440-8. doi: 10.1111/j.1541-0420.2007.00922.x. Epub 2007 Oct 26.
5
A penalized latent class model for ordinal data.一种用于有序数据的惩罚潜在类别模型。
Biostatistics. 2008 Apr;9(2):249-62. doi: 10.1093/biostatistics/kxm026. Epub 2007 Jul 11.
6
Fitting semiparametric random effects models to large data sets.将半参数随机效应模型应用于大型数据集。
Biostatistics. 2007 Oct;8(4):821-34. doi: 10.1093/biostatistics/kxm008. Epub 2007 Apr 11.
7
Feature-specific penalized latent class analysis for genomic data.用于基因组数据的特征特异性惩罚潜在类别分析。
Biometrics. 2006 Dec;62(4):1062-70. doi: 10.1111/j.1541-0420.2006.00566.x.
8
Expression of oligodendroglial and astrocytic lineage markers in diffuse gliomas: use of YKL-40, ApoE, ASCL1, and NKX2-2.少突胶质细胞和星形胶质细胞谱系标志物在弥漫性胶质瘤中的表达:YKL-40、载脂蛋白E、achaete-scute复合体样蛋白1和NKX2-2的应用
J Neuropathol Exp Neurol. 2006 Dec;65(12):1149-56. doi: 10.1097/01.jnen.0000248543.90304.2b.
9
Identifying genes that contribute most to good classification in microarrays.识别在微阵列中对良好分类贡献最大的基因。
BMC Bioinformatics. 2006 Sep 7;7:407. doi: 10.1186/1471-2105-7-407.
10
YKL-40 is a differential diagnostic marker for histologic subtypes of high-grade gliomas.YKL-40是高级别胶质瘤组织学亚型的鉴别诊断标志物。
Clin Cancer Res. 2005 Mar 15;11(6):2258-64. doi: 10.1158/1078-0432.CCR-04-1601.

监督贝叶斯潜在类别模型在高维数据中的应用。

Supervised Bayesian latent class models for high-dimensional data.

机构信息

Division of Biostatistics and Epidemiology, Department of Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.

出版信息

Stat Med. 2012 Jun 15;31(13):1342-60. doi: 10.1002/sim.4448. Epub 2012 Apr 11.

DOI:10.1002/sim.4448
PMID:22495652
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3701307/
Abstract

High-grade gliomas are the most common primary brain tumors in adults and are typically diagnosed using histopathology. However, these diagnostic categories are highly heterogeneous and do not always correlate well with survival. In an attempt to refine these diagnoses, we make several immunohistochemical measurements of YKL-40, a gene previously shown to be differentially expressed between diagnostic groups. We propose two latent class models for classification and variable selection in the presence of high-dimensional binary data, fit by using Bayesian Markov chain Monte Carlo techniques. Penalization and model selection are incorporated in this setting via prior distributions on the unknown parameters. The methods provide valid parameter estimates under conditions in which standard supervised latent class models do not, and outperform two-stage approaches to variable selection and parameter estimation in a variety of settings. We study the properties of these methods in simulations, and apply these methodologies to the glioma study for which identifiable three-class parameter estimates cannot be obtained without penalization. With penalization, the resulting latent classes correlate well with clinical tumor grade and offer additional information on survival prognosis that is not captured by clinical diagnosis alone. The inclusion of YKL-40 features also increases the precision of survival estimates. Fitting models with and without YKL-40 highlights a subgroup of patients who have glioblastoma (GBM) diagnosis but appear to have better prognosis than the typical GBM patient.

摘要

高级别神经胶质瘤是成年人中最常见的原发性脑肿瘤,通常通过组织病理学诊断。然而,这些诊断类别高度异质,并不总是与生存情况很好地相关。为了尝试改进这些诊断,我们对 YKL-40 进行了几项免疫组织化学测量,YKL-40 是一种先前显示在诊断组之间差异表达的基因。我们提出了两种潜在类别模型,用于在存在高维二进制数据的情况下进行分类和变量选择,使用贝叶斯马尔可夫链蒙特卡罗技术进行拟合。在这种情况下,通过对未知参数的先验分布进行惩罚和模型选择。这些方法在标准监督潜在类别模型无法提供有效参数估计的条件下提供了有效的参数估计,并且在各种情况下都优于两阶段变量选择和参数估计方法。我们在模拟中研究了这些方法的特性,并将这些方法应用于神经胶质瘤研究,在没有惩罚的情况下,无法获得可识别的三类别参数估计。通过惩罚,得出的潜在类别与临床肿瘤分级密切相关,并提供了仅凭临床诊断无法捕捉到的生存预后的额外信息。包含 YKL-40 特征还提高了生存估计的精度。拟合有和没有 YKL-40 的模型突出了一组患者,他们被诊断为胶质母细胞瘤 (GBM),但似乎比典型的 GBM 患者预后更好。